Print the page
Increase font size

Posted December 02, 2020

Byron King

By Byron King

The Hindenburg of Electric Vehicles?

We learn this morning the U.K. has approved the Pfizer/BioNTech vaccine

covid vaccine

We wont get into the medical breakthrough this represents -- specifically for mRNA technology -- or the prohibitive hurdles of cold storage and Brexit but for our readers, does this approval change your mind about getting the vaccine yourself?

Send your opinions to,

Your Rundown for Wednesday, Dec. 2, 2020

The Wheels Fall Off an Intricate Fraud?

We promised wed keep you posted about an unfolding scandal in the electric vehicle (EV) space.

Although it feels like a lifetime ago in this pandemic hellscape, in September, Detroit automaker GM hammered out a deal with electric vehicle up-and-comer Nikola Motor Company.

If you recall, General Motors planned to sink $2 billion into Nikola (ticker: NKLA), and take an 11% stake in the Phoenix-based company. With GMs backing, the electric Badger truck was expected to roll out by the end of 2022

tesla badger

Courtesy: Nikola Motor Companys website

Nikolas Badger

But soon after the announcement of the GM partnership, the wheels started falling off what Hindenburg Research (the irony) called an intricate fraud.

Hindenburg reported Nikola had taken credit for technology that actually belonged to a second-party vendor, deceiving shareholders (and presumably stakeholders like GM). After the revelation, Nikola CEO Trevor Milton promptly resigned.

Then on Monday, according to The Arizona Republic, we learned: General Motors has canceled a planned $2 billion investment in Phoenix-based Nikola Motors and the Detroit car giant won't help develop the electric-vehicle company's Badger pickup truck as planned. Also canceled? GMs 11% stake in NKLA.

In addition, Nikola announced it will "refund all previously submitted order deposits for the Badger," amounting to $6.9 million, according to Nikola's quarterly financial filing.

While it appears GM is slowly backing away from Nikola, the two companies signed a new memorandum of understanding that calls for the use of GM hydrogen fuel-cell technology in Nikola's medium- and long-haul big rigs. Or prototypes that might roll out late next year or early 2022.

Our takeaway? We once asked if Mr. Milton was the yin to Elon Musks yang Apparently not. And with NKLA stock imploding -- and allegations of chicanery -- we question Nikolas survival.

Market Rundown for Wednesday, Dec. 2, 2020

S&P 500 futures are down 10 points to 3,650.

Oils static at $44.51 for a barrel of West Texas crude.

Gold has added $3.00 to its price at $1,821.90 per ounce.

Bitcoins jumped $361.75 to $19,158.40.

Send your comments and questions to,

Well be back Friday, and we welcome your feedback: Does the U.K.s approval of the first COVID-19 vaccine change your mind about the vaccine -- one way or another?

For the Rundown,

Aaron Gentzler

Aaron Gentzler

Inflation and Supply Chain Worries Mean Opportunity

Posted June 21, 2021

By Aaron Gentzler

Today’s Rundown reviews a recent conversation we had with Editor Ray Blanco. Ray discusses semiconductors as well as inflation and supply chain worries. Then, we take a look at the markets this morning.

$1,000 Sign Up Bonus To Work Part-Time at an Arcade

Posted June 18, 2021

By Aaron Gentzler

Today we take a look at Ford’s recent run of good fortune and forecast what could come next for the stock. We also feature a reader letter about wages and the free market.
A Meme Stock ETF

A Meme Stock ETF

Posted June 16, 2021

By Aaron Gentzler

We think an ETF pegged exclusively to meme stocks must be in the works. We’re calling it now…

Novavax: Competitive Advantages ‘Boost’ Profits

Posted June 14, 2021

By Aaron Gentzler

Novavax announced its Covid-19 vaccine… So what’s next for the Maryland-based biotech company?
Make America Competitive Again

Make America Competitive Again

Posted June 11, 2021

The Senate passed the U.S. Innovation and Competition Act (USICA). The bill aspires to make America competitive again… and takes aim at China.
Biogen Breaks Through 5-Year Stalemate

Biogen Breaks Through 5-Year Stalemate

Posted June 09, 2021

“This could be a key moment for the biotech sector,” says our chief market analyst Greg Guenthner.